« Previous
Next »
Nuclear Medicine and Biology
Volume 37, Issue 2
, Pages 125-132
, February 2010
Hypoxia-induced redox alterations and their correlation with 99mTc-MIBI and 99mTc-HL-91 uptake in colon cancer cells
References
- . Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. Cancer. 2005;104:2035–2047
- Hypoxic cell turnover in different solid tumor lines. Int J Radiat Oncol Biol Phys. 2005;62:1157–1168
- Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. Int J Radiat Oncol Biol Phys. 2006;65:246–254
- . Tumor hypoxia: a target for selective cancer therapy. Cancer Sci. 2003;94:1021–1028
- . Determinants of tumor blood flow: a review. Cancer Res. 1988;48:2641–2658
- . Heterogeneous vascular dependence of tumor cell populations. Am J Pathol. 2001;158:1325–1334
- . Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol. 2001;18:243–259
- . Nuclear medicine applications in molecular imaging: 2007 update. Q J Nucl Med Mol Imaging. 2007;51:99–110
- . Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy. 2007;53:233–256
- . Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med. 1997;3:177–182
- . Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159–163
- . The redox-sensitive human antioxidant responsive element induces gene expression under low oxygen conditions. Carcinogenesis. 1998;19:1333–1337
- . Measurement of tumor hypoxia using single-cell methods. Semin Radiat Oncol. 2004;14:241–248
- . Methods for noninvasive imaging of tissue hypoxia. Antioxid Redox Signal. 2007;9:1745–1756
- . Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19–20, 1992, at the National Cancer Institute, Bethesda, Maryland, Radiat Res. 1993;136:422–434
- . Potential technetium small molecule radiopharmaceuticals. Chem Rev. 1999;99:2205–2218
- . Neutral and stereospecific Tc-99m complexes: [99mTc]N-benzyl-3,4-di-(N-2-mercaptoethyl)-amino-pyrrolidines (P-BAT). Nucl Med Biol. 1999;26:217–224
- . Evaluation of 99mTc(CO)3 complex of 2-methyl-5-nitroimidazole as an agent for targeting tumor hypoxia. Bioorg Med Chem. 2006;14:7666–7670
- . Metal complexes as diagnostic tools. Coord Chem Rev. 1999;184:3–66
- . Recent advances on technetium complexes: coordination chemistry and medical applications. J Coord Chem. 2006;59:1–63
- . Hypoxic sensitizers—implications for radiation therapy. N Engl J Med. 1979;301:1429–1432
- . Imaging hypoxia in tumors. Semin Nucl Med. 2001;31:321–329
- . An efficient synthesis of some 6-substituted 4,8-diaza-3,3,9,9-tetramethylundeca-2,10-dione dioximes (propylene amine oximes, Pnaos) — ligands for Tc-99m complexes used in structure distribution relationship (Sdr) studies. Tetrahedron. 1994;50:8617–8632
- . Radiometal complexes that localize in hypoxic tissues. US Patent 5997843. 1999;
- . 99mTc-Propylene amine oxime (99mTc-PnAO); a potential brain radiopharmaceutical. Eur J Nucl Med. 1984;9:511–516
- . In: Technetium labelled agents for imaging tissue hypoxia in vivo. SGE Ditoriali Publishers; 1995;p. 535–539
- . Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 1993;53:977–984
- Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry. 1999;37:197–204
- . Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol. 2004;142:231–255
- . Hypoxia decreases cellular ATP demand and inhibits mitochondrial respiration of a549 cells. Am J Respir Cell Mol Biol. 2005;32:44–51
- . Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG. J Nucl Med. 1998;39:99–103
- . Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist. 2008;13(Suppl 3):21–26
- . Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res. 2002;90:1274–1281
- Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91. Eur J Nucl Med Mol Imaging. 2002;29:1006–1011
- . Hypoxic coordinate regulation of mitochondrial enzymes in mammalian cells. Science. 1984;223:707–709
- . Enzymatic basis for bioenergetic differences of alveolar versus peritoneal macrophages and enzyme regulation by molecular O2. J Clin Invest. 1977;59:443–448
- . Injury to primary cultures of rat heart endothelial cells by hypoxia and glucose deprivation. In Vitro. 1979;15:929–934
- . Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways. FASEB J. 2004;18:1906–1908
- . Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res. 2007;67:7368–7377
PII: S0969-8051(09)00276-5
doi: 10.1016/j.nucmedbio.2009.11.001
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Nuclear Medicine and Biology
Volume 37, Issue 2
, Pages 125-132
, February 2010
